OrisDx Inc. — Form D
OrisDx Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-16. The offering totals $4.0M, of which $2.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-07-16
- Form: D
- Accession: 0002074140-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.8M
- Remaining: $1.2M
- Investors: 25
- Date of first sale: 2025-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-551890
Issuer
- Name: OrisDx Inc.
- CIK: 0002074140
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 363 E WACKER DRIVE, CHICAGO, IL, 60601
- Phone: 630-800-7379
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Nishant Agrawal | Director | Chicago, IL |
| Evgeny Izmchenko | Director | Countryside, IL |
| Harald Steltzer | Director | Chicago, IL |
| Patrick Conniff | Executive Officer | Chicago, IL |
| Harald Steltzer | Executive Officer | Chicago, IL |
More